While GLP-1s have revolutionized healthcare, they come at a cost
This review aims to give extensive coverage of the intricate nature of PPH common with bariatric and metabolic surgery, outlining its pathogenesis, risk factors, clinical presentation, diagnostic strategies, and treatment options
not FDA-approved and not therapeutically equivalent to Mounjaro or Zepbound Ro offers a broader medication catalog, including FDA-approved brand options As of July 2026, Ro has fully exited compounded GLP-1s and provides access only to FDA-approved brand-name medication paths through its membership platform
The unexpected effects: its not just about weight One of the strongest insights from the survey: 1 in 5 women said cycle changes were the most unexpected effect
NAD+ helps with cognitive function and mitochondrial repair, whereas B12 is crucial for nerve function and preventing deficiencies